14 Georgetown Oval
New City, NY 10956
Tel: 845-634-4491
Fax: 845-634-7639
Gerald J. Siuta, Ph.D., CLP
Dr. Gerald J. Siuta, President, founded Siuta Consulting in 1995. He began his professional career with the Medical Research Division of American Cyanamid Company in 1974 as a synthetic organic chemist preparing novel compounds for the treatment of asthma, atherosclerosis, diabetes, rheumatoid arthritis and ulcers. He is a co-inventor on 16 issued United States patents and an author of numerous publications.
In 1981 he moved into Cyanamid's New Product Licensing Department where his responsibilities included identifying early stage licensing opportunities from universities, research institutes and U.S. government laboratories to supplement Cyanamid's medical research programs. Among his many accomplishments, he identified and negotiated licenses for a hypolipidemic agent and several poliovirus vaccine technologies from U.S. universities, a novel anticancer agent from a European academic institution, and tumor selective monoclonal antibodies, DNA clones and transgenic animals from the U.S. government.
Dr. Siuta was also involved with the in-licensing of new pharmaceutical products including SUPRAX® cefixime, an oral cephalosporin antibiotic from Fujisawa and tazobactam, a beta-lactamase inhibitor from Taiho. Dr. Siuta out-licensed Cyanamid research compounds and technologies that were considered to be outside the scope of the company's strategic intent. Most notably, he licensed Cyanamid's AZMACORT® triamcinolone acetonide aerosol inhaler for the treatment of asthma that provided Cyanamid with more than $6 million in annual royalties.
With more than 43 years of experience in the licensing field, Dr. Siuta has established an extensive network of licensing contacts at pharmaceutical and biotechnology companies in the United States, Europe and Japan as well as at Technology Transfer Offices in universities and research institutes in the United States, Canada, Europe, Australia and New Zealand. He also has contacts within U.S. government laboratories.
During his career, Dr. Siuta has made numerous presentations on licensing new technologies and products to the pharmaceutical and biotechnology industries at conferences sponsored by the Licensing Executives Society (LES), Association of University Technology Managers (AUTM), American Conference Institute, Technology Transfer Conferences, Inc., World Intellectual Property Organization (WIPO), Biotechnology Industry Organization (BIO), McLaughlin-Rotman Centre for Global Health, National Institutes of Health, Centre for Management of Intellectual Property in Health Research and Development (MIHR), Africa Genome Education Institute, Law Seminars International, New York Biotechnology Association and GTCbio.
Dr. Siuta received his Bachelor of Arts Degree in Chemistry from Hunter College of The City University of New York and his Ph.D. in Organic Chemistry from Fordham University. He is a member of the American Chemical Society, Sigma Xi - The Scientific Research Society of North America and Phi Lambda Upsilon - The National Honorary Chemical Society. He is a former member of the Association of University Technology Managers where he served as Vice President for Affiliate Members and the Licensing Executives Society where he served on the Board of Trustees. He has also previously served on the Advisory Board of Technology Transfer Conferences, Inc., the Dean's Advisory Board at the Fordham University Graduate School of Arts and Sciences, and the External Advisory Board of the Center for Molecular Medicine and Genetics Commercialization Center at Wayne State University.